Agoracom Blog Home

Archive for the ‘AI/ML Innovations Inc.’ Category

AI/ML’s $AIML.ca $FIRZF CEO Appointed to Advisory Board of ST Innovations $PFM.ca $DM.ca $ADK.ca

Posted by AGORACOM-AB at 3:39 PM on Tuesday, March 2nd, 2021
AI/ML Innovations Inc.

TORONTO , March 2, 2021 – AI/ML Innovations Inc. (CSE: AIML), a company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that Randy Duguay, CEO of AI/ML Innovations Inc., was appointed to the University of Alberta’s ST Innovations Advisory Board in order to provide input and guidance regarding the commercialization of new technologies in the field of digital health innovations.

“The addition of Randy Duguay to this prestigious advisory board is mutually beneficial” said Tim Daniels , Executive Chairman of AI/ML Innovations Inc.

“Randy is able to share his wealth of expertise and experience in the field of digital health by mentoring and advising others, while simultaneously leveraging the human and technological resources of ST Innovations to the benefit of AI/ML Innovations.”

ST Innovations, the business arm of the University of Alberta’s SMART Network, is Alberta’s leading R&D services organization, connecting entrepreneurs with world-class researchers in support of the latest innovation and R&D.

Read More: https://agoracom.com/ir/AIMLInnovations/forums/discussion/topics/756368-ai-ml-s-ceo-appointed-to-advisory-board-of-st-innovations/messages/2306045#message

AI/ML Innovations $AIML.ca $FIRZF Retains North Equities Corp $ADK.ca $DM.ca $PFM.ca

Posted by AGORACOM-AB at 12:42 PM on Thursday, February 25th, 2021
AI/ML Innovations Inc.

TORONTO, ON / ACCESSWIRE / February 25, 2021 / AI/ML Innovations Inc. (CSE:AIML), a company focused on acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, reports that it has engaged Toronto-based marketing firm North Equities Corp. (“North Equities”) that specializes in various social media platforms, to facilitate greater investor engagement and widespread dissemination of the Company’s news.

In addition to press releases, the Company will be posting important information and updates through videos on the official Company YouTube Channel: https://www.youtube.com/channel/UCCfOj2P_Fu3TOK6Jl1G9vEQ

In accordance with the terms of the agreement, the Company will issue 80,645 common shares at a deemed price of $1.24 per share to North Equities, for a 6-month engagement ending 15/08/21. These shares are subject to a statutory hold period ending 24/06/21.

Read More: https://agoracom.com/ir/AIMLInnovations/forums/discussion/topics/756055-ai-ml-innovations-retains-north-equities-corp/messages/2305330#message

AI/ML Innovation’s $AIML.ca $FIRZF Health Gauge Awarded $330,000 in Grants from Public Sector Innovation Partners $ADK.ca $DM.ca $PFM.ca

Posted by AGORACOM-AB at 9:56 AM on Tuesday, February 9th, 2021
AI/ML Innovations Inc.
  • Health Gauge was awarded a $140,000 Alberta Innovates development grant
  • Health Gauge has also received grants totalling $130,000 from the National Research Council Canada
  • It was also granted more than $60,000 from MITACs Canada, which designs and delivers research and training programs in Canada

TORONTO, ON / ACCESSWIRE / February 9, 2021 / AI/ML Innovations Inc. (CSE:AIML), a company focused on acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, reports that its subsidiary, Health Gauge, has been awarded a total of $330,000 in grants from Public Sector Innovation Partners as it continues to forge numerous strategic private and public sector relationships, so that it may best leverage the human, technological and financial resources of world-class organizations in order to most efficiently and effectively commercialize its AI-driven, health-tech platform.

Health Gauge is directly benefitting from partnerships with many leading organizations in the form of non-dilutive grants, the development of business networks, access to leading complimentary technologies, and specialized input from industry leaders, healthcare entrepreneurs, and scientists from across North America. Health Gauge continues to tap into its strong industry relationships to pursue opportunities for further partnerships and non-dilutive funding to maximize shareholder value.

“Health Gauge has attracted the attention and support of a broad array of first-class organizations, all of which the Company is using to advance its technology, business model and deployment strategy” said Tim Daniels, Executive Chairman of AI/ML Innovations Inc. “We view the meaningful financial support by these prominent organizations as a vote of confidence in both Health Gauge’s technology and its vision.”

Read More: https://agoracom.com/ir/AIMLInnovations/forums/discussion/topics/754960-ai-ml-s-health-gauge-was-awarded-330-000-in-grants-from-public-sector-innovation-partners/messages/2302799#message

AI/ML Innovations $AIML.ca $FIRZF Introduces Health Gauge’s Advisory Board Members $ADK.ca $PFM.ca $DM.ca

Posted by AGORACOM-AB at 9:53 AM on Tuesday, February 2nd, 2021

TORONTO, ON / February 2, 2021 / AI/ML Innovations Inc. (CSE:AIML), a company focused on acquiring and furthering Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to introduce the following members of the Advisory Board for its subsidiary, Health Gauge:

Dr. Pierre Boulanger, P.Eng , PhD, University of Alberta

Dr. Boulanger is a Professor and Cisco Chair in Healthcare, at the University of Alberta. He holds a double appointment of Professor at the University of Alberta’s Department of Computing Science (where he is the Director of the Advanced Man-Machine Interface Laboratory) and the Department of Radiology and Diagnostic Imaging. He is also on the editorial board of two major academic journals and sits on several international academic committees.

Dr. Jacques Kpodonu, MD, FACC

Dr. Kpodonu is a triple US boarded cardiac and endovascular surgeon based at the Beth Israel Deaconess Medical Center and surgical faculty at Harvard Medical School. Additionally, he is a visionary clinician, medical scientist, and the lead author and editor of four medical textbooks as well as having regularly published work on topics including digital health, biomedical innovation, design of hybrid operating rooms and recently addressing health equity during the COVID19 pandemic.

Read More: https://agoracom.com/ir/AIMLInnovations/forums/discussion/topics/754419-ai-ml-introduces-health-gauge-s-advisory-board-members/messages/2301562#message

VIDEO – AI/ML Innovations $AIML.ca $FIRZF Uses #AI & Machine Learning to Make Waves in The $245bn Global Digital Health Monitoring Market $ADK.ca $PFM.ca $DM.ca

Posted by AGORACOM-JC at 10:32 AM on Thursday, January 28th, 2021

Tim Daniels / Executive Chairman of AI/ML Innovations Inc. / (CSE:AIML / OTC:FIRZF) explains how the Toronto-based business is focusing on acquiring and furthering Artificial Intelligence and Machine Learning technologies that can address urgent societal needs.

The firm’s key subsidiary, Health Gauge, is a leading digital health solutions provider that’s poised to disrupt the traditional healthcare industry by providing A.I. innovations and services that improve health outcomes, while at the same time reducing costs and stresses on the overburdened healthcare infrastructure. 

AI/ML Highlights:

  • Recently showcased its proof-of-concept deployment in a study funded by The Bill and Melinda Gates Foundation
  • Health Gauge aims to penetrate the $245bn global digital health monitoring market by partnering with leading channel partners, health benefits providers, and end-users
  • Will do this via its proprietary combination of digital health monitoring devices, AI-based software, and cloud computing platform.

 Take a seat and learn more about AI/ML and its ambitious vision for the future.

AI/ML’s $AIML.ca $FIRZF Health Gauge announces successful Proof of Concept deployment and findings for study funded by The Bill and Melinda Gates Foundation $ADK.ca $PFM.ca $DM.ca

Posted by AGORACOM-JC at 8:09 AM on Tuesday, January 26th, 2021
  • Subsidiary, Health Gauge, successfully displayed its proof-of-concept deployment in a study funded by The Bill and Melinda Gates Foundation, further validating its technology.
  • Health Gauge was invited in 2019 to participate, as the sole technology provider, in a Bill and Melinda Gates Foundation funded initiative with ICDDR , B (the International Centre for Diarrhoeal Disease Research of Bangladesh) on a research project to study ways to reduce pregnancy complications and mortality, by making healthcare more accessible using wearable solutions.

January 20, 2021 – AI/ML Innovations Inc. (CNSX :AIML.CN ) (OTC:FIRZF) , a company focused on acquiring and furthering Artificial Intelligence/Machine Learning technologies that address urgent societal needs, announces that its subsidiary, Health Gauge, successfully displayed its proof-of-concept deployment in a study funded by The Bill and Melinda Gates Foundation, further validating its technology. Health Gauge was invited in 2019 to participate, as the sole technology provider, in a Bill and Melinda Gates Foundation funded initiative with ICDDR , B (the International Centre for Diarrhoeal Disease Research of Bangladesh) on a research project to study ways to reduce pregnancy complications and mortality, by making healthcare more accessible using wearable solutions. Health Gauge was invited to participate in this study as a result of ICDDR,B’s learning of Health Gauge’s break-through solution in digital pulse and ECG analysis, using simple, affordable, and quality digital signal capture.  For this study, Health Gauge’s personal health monitoring solution, including its wearable device, smart phone app, and AI-driven cloud processing platform was used, in conjunction with the support of community-based health service providers.

Conclusion

Studies such as this validate the proof-of-concept of Health Gauge’s products, and show the vast and varied commercial opportunities available within Health Gauge’s bespoke business model. It speaks to the merits and importance of how Health Gauge’s latest generation solutions can help solve important community health problems, in affordable ways, while readily fitting into existing managed care programs – anywhere. Physicians, other healthcare professionals, and individuals can apply and adapt the Health Gauge solution to a number of different health conditions and settings for personal health monitoring and management – showing the larger value of Health Gauge’s device and applications.

Blood pressure related pregnancy maladies are of concern globally, and a leading cause of death amongst pregnant women. Health Gauge’s products have both the ability and opportunity to capitalize on this critical women’s health issue, while providing an invaluable service that has a direct impact on health outcomes.

Background

The study, which commenced in 2019, focused on serving pregnant women who were at risk of developing eclampsia, a hypertension-related significant health risk. Hypertensive disorders of pregnancy (HDP) are extremely dangerous to both the mother and child, and are in fact one of the three leading causes of maternal death worldwide. While hypertension complicates 10% of all pregnancies and is responsible for 14% for all maternal deaths globally, in the developing world it is of even greater concern where mortality rates can be as high as 20%.

Read More: https://agoracom.com/ir/AIMLInnovations/forums/discussion/topics/753924-ai-ml-s-health-gauge-announces-successful-proof-of-concept-deployment-and-findings-for-study-funded-by-the-bill-and-melinda-gates-foundation/messages/2300216#message